Dr Reddy’s Debuts Two Revlimid Exclusives As Part Of Complete Launch In US

End Of Teva Exclusivity Period Opens Door For Several Lenalidomide ANDA Approvals

Launches Neon Sign Brick Wall
Dr Reddy’s has launched multiple presentations of lenalidomide, two with exclusivity • Source: christitzeimaging.com / Alamy Stock Photo
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Products

More from Generics Bulletin